Pulmonary toxicity of cholinesterase inhibitors

Toxicology of Organophosphate & Carbamate Compounds

Volumn , Issue , 2006, Pages 389-397

  Hilmas, Corey ^a   Adler, Michael ^a   Baskin, Steven I ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882897546     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088523-7/50029-6     Document Type: Chapter

References (76)

1. Adler M., Moore D.H., Filbert M.G. Effects of anticholinesterases on airway smooth muscle. Clinical & Experimental Toxicology of Organophosphates and Carbamates 1992, 149-155. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
2. Adrian E.D., Feldberg W., Kilby B.A. The cholinesterase inhibitory action of flurophosphonates. Br. J. Pharmacol. 1947, 2:56-58.
3. Berkowitz G.S., Obel J., Deych E., Lapinski R., Godbold J., Liu Z., Landrigan P.J., WolffM.S. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ. Health Perspect. 2003, 111:79-84.
4. Berman H.A., Decker M.M. Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography. J. Biol. Chem. 1986, 261:10646-10652.
5. Bowers M.B., Goodman E., Sim V.M. Some behavioral changes in man following anticholinesterase administration. J. Nervous Mental Dis. 1964, 138:383-389.
6. Caldwell R.W., Lowensohn H.S., Chryssanthis M.A., Nash C.B. Interactions of pyridostigmine with cardiopulmonary systems and their relationships to plasma cholinesterase activity. Fundam. Appl. Toxicol. 1989, 12:432-441.
7. Clements J.A., Moore J.C., Johnson R.P., Lynott J. Observations on airway resistance in men given low doses of GB by chamber exposure. MLR Report No. 122 1952, Medical Laboratories Research, Edgewood Arsenal, MD.
8. Clothier B., Johnson M.K., Reiner E. Interaction of some trialklphosphorothiolates with acetylcholinesterase. Characterisation of inhibition, aging and reactivation. Biochim. Biophys. Acta 1981, 660:306-316.
9. Coulson F.R., Fryer A.D. Muscarinic acetylcholine receptors and airway disease. Pharmacol. Ther. 2003, 98:59-69.
10. Craig A.B., Cornblath M. Further clinical observations on workers accidentally exposed to "G" agents. MLR Report No. 234 1953, Medical Laboratories Research, Edgewood Arsenal, MD.
11. Craig A.B., Freeman G. Clinical observations on workers accidentally exposed to "G" agents. MLR Report No. 154 1953, Medical Laboratories Research, Edgewood Arsenal, MD.
12. Craig F.N., Cummings E.G., Sim V.M. Environmental temperature and the percutaneous absorption of a cholinesterase inhibitor, VX. J. Invest. Dermatol. 1977, 68:357-361.
13. Dahl A.R., Bechtold W.E. Deposition and clearance of a water-reactive vapor, methylphosphonic difluoride (difluoro), inhaled by rats. Toxicol. Appl. Pharmacol. 1985, 81:58-66.
14. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994, 14:317-331.
15. DeCandole C.A., Douglas W.W. The mechanism of respiratory arrest after GB poisoning. Porton Technical Paper 1949, (No. 149).
16. DeCandole C.A., Douglas W.W., Evans C.L. The failure of respiration in death by anticholinesterase poisoning. Br. J. Pharmacol. Chemother. 1953, 8:466-475.
17. Deschamps D., Questel F., Baud F.J., Gervais P., Dally S. Persistent asthma after acute inhalation of organophosphate insecticide. Lancet 1994, 344:1712.
18. Diggle W.M., Gage J.C. Cholinesterase inhibition in vitro by O, O-diethyl O-p-nitrophenyl thiophosphate (parathion, E 605). Biochem. J. 1951, 49:491-494.
19. Dinsdale D. Pulmonary toxicity of anticholinesterases. Clinical & Experimental Toxicology of Organophosphates and Carbamates 1992, 156-166. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
20. Dinsdale D., Verschoyle R.D. Comparative toxicity of two trialkylphosphorothioates to rat lung and the effects of atropine sulphate pretreatment. Arch. Toxicol. Suppl. 1988, 12:432-434.
21. Douglas W.W. An effect of atropine in GB poisoning in the cat. Porton Technical Paper 1950, (No. 195).
22. Douglas W.W., Matthews P.B.C. Acute TEPP poisoning in cats and its modifications by atropine and hyoscine. J. Physiol. 1952, 116:202.
23. DuBois K.P., Doull J., Salerno P.R., Coon J.M. Studies on the toxicity and mechanisms of action of p-nitrophenyl diethyl thionosphosphate (parathion). J. Pharmacol. Exp. Ther. 1949, 95:79-91.
24. Fenske R.A., Lu C., Barr D., Needham L. Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. Environ. Health Perspect. 2002, 110:549-553.
25. Freeman A.M., Himwich H.E. DFP: Site of injection and variation in response. Am. J. Physiol. 1949, 156:125.
26. Freeman G., Hilton K.C., Brown E.S. V poisoning in man. CWL Report No. 2025 1956, Chemical Warfare Laboratories, Edgewood Arsenal, MD.
27. French M.C., Wetherell J.R., White P.D. The reversal by pyridostigmine of neuromuscular block produced by soman. J. Pharm. Pharmacol. 1979, 31:290-294.
28. Fryer A.D., Lein P.J., Howard A.S., Yost B.L., Beckles R. Al, Jett D.A. Mechanisms of organophosphate insecticide-induced airway hyperreactivity. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L963-L969.
29. Gage J.C. A cholinesterase inhibition derived from O, O-diethyl O-p-nitrophenyl thiophosphate in vivo. Biochem. J. 1953, 54:426-430.
30. Gordon J.J., Leadbeater L., Maidment M.P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 1978, 43:207-216.
31. Grob D., Harvey A.M. The effects and treatment of nerve gas poisoning. Am. J. Med. 1953, 14:52-63.
32. Grob D., Harvey J.D. Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J. Clin. Invest. 1958, 37:350-368.
33. Grob D., Lilienthal J.L., Harvey A.M., Jones B.F. The administration of di-isopropyl fluorophosphates (DFP) to man. I. Effect on plasma and erythrocyte cholinesterase; General systemic effects; Use study of hepatic function and erythropoiesis; And some properties of plasma cholinesterase. Bull. Johns Hopkins Hosp. 1947, 81:217-244.
34. Guyton A.C., Hall J.E. Textbook of Medical Physiology 2005, Saunders, Philadelphia. 11th ed.
35. Harris R., Paxman J. A Higher Form of Killing 1982, Hill & Wang, New York.
36. Hartert T.v., Peebles R.S. Epidemiology of asthma: The year in review. Curr. Opin. Pulm. Med. 2000, 6:4-9.
37. Ho I.K., Hoskins B. Biological and pharmacological aspects of neurotoxicity from and tolerance to organophosphorus cholinesterase inhibitors. Handbook of Toxicology 1987, 44-73. Hemisphere, Washington, DC. T.J. Haley, W.O. Berndt (Eds.).
38. Holmes R. The mechanism of respiratory failure in the rabbit poisoned with GB. Porton Technical Paper 1952, (No. 275).
39. Holmes R. The cause of death from acute anticholinesterase poisoning in the the rabbit, can and monkey. Porton Technical Paper 1953, (No. 356).
40. Holmstedt B. Structure-activity relationships of the organophosphorus anticholinesterase agents. Cholinesterases and Anticholinesterase Agents 1963, Spinger-Verlag, Berlin. G.B. Koelle (Ed.).
41. Imamura T., Gandy J., Fukuto T.R. An impurity of malathion alters the morphology of rat lung bronchiolar epithelium. Toxicology 1983, 26:73-79.
42. Johns R.J. The effects of low concentrations of GB on the human eye. MRL Report No. 100 1952, Medical Research Laboratory, Edgewood Arsenal, MD.
43. Johnson R.P., Gold A.J., Freeman G. Comparative lung-airway resistance and cardiovascular effects in dogs and monkeys following parathion and sarin intoxication. Am. J. Physiol. 1958, 192:581-584.
44. Kluwe W.M., Chinn J.C., Feder P., Olson C., Joiner R. Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model. Report No. AD B121516 1987, 226-234. U.S. Army Medical Research Institute for Chemical Defense, Aberdeen Proving Ground, MD.
45. Koch D., Lu C., Fisker-Andersen J., Jolley L., Fenske R.A. Temporal association of children's pesticide exposure and agricultural spraying: Report of a longitudinal biological monitoring study. Environ. Health Perspect. 2002, 110:829-833.
46. Krivoy W.A., Marrazzi A.S. Evaluation of the central action of antichonesterases in producing respiratory paralysis. Fec. Proc. 1951, 10:316.
47. Krivoy W.A., Hart E.R., Marrazzi A.S. Further analysis of the actions of DFP and curare on the respiratory center. J. Pharmacol. Exp. Ther. 1951, 103:351.
48. Krop S., Kunkel A.M. Observations on pharmacology of the anticholinesterases sarin and tabun. Proc. Soc. Exp. Biol. Med. 1954, 86:530-533.
49. Lein P.J., Fryer A.D. Organophosphorus insecticides induce airway hyperreactivity by decreasing neuronal M2 muscarinic receptor function independent of acetylcholinesterase inhibition. Toxicol. Sci. 2005, 83:166-176.
50. Lu C., Knutson D.E., Fisker-Andersen J., Fenske R.A. Biological monitoring survey of organophosphorus pesticide exposure among preschool children in the Seattle metropolitan area. Environ. Health Perspect. 2001, 109:299-303.
51. Lubash G.D., Clark B.J. Some metabolic studies in humans following percutaneous exposure to VX. CRDL Report No. 3003 1960, Chemical Research and Development Laboratory, Edgewood Arsenal, MD.
52. Marino M.T., Schuster B.G., Bruckner R.P., Lin E., Kaminskis A., Lasseter K.C. Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J. Clin. Pharmacol. 1998, 38:227-235.
53. Marrs T.C., Maynard R.L., Sidell F.R. Chemical Warfare Agents, Toxicology and Treatment 1996, Wiley, New York.
54. Minette P.A., Barnes P.J. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J. Appl. Physiol. 1988, 64:2532-2537.
55. Modell W., Krop S., Hitchcock P., Riker W.F. General systemic actions of DFP in cats. J. Pharmacol. Exp. Ther. 1946, 87:400.
56. O'Brien R.D. Toxic Phosphorus Esters: Chemistry, Metabolism, and Biological Effects 1960, Academic Press, New York.
57. O'Malley M. Clinical evaluation of pesticide exposure and poisonings. Lancet 1997, 349:1161-1166.
58. Pant S.C., Vijayaraghavan R., Das Gupta S. Sarin induced lung pathology and protection by standard therapy regime. Biomed. Environ. Sci. 1993, 6:103-111.
59. Rickett D.L. Soman produced respiratory arrest: Differentiation of brain stem and neuromuscular actions. USAMRDC Chem. Prog. Rev. [abstract] 1981, June 8-9.
60. Rickett D.L., Glenn J.F., Beers E.T. Central respiratory effects versus neuromuscular actions of nerve agents. Neuro Toxicology 1986, 7:225-236.
61. Robinson J.P. The rise of CB weapons. The Problem of Chemical and Biological Warfare 1971, Humanities Press, New York.
62. Roffel A.F., Elzinga C.R., Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm. Pharmacol. 1990, 3:46-51.
63. Roffel A.F., Meurs H., Zaagsma J. Muscarinic acetylcholine receptors and control of smooth muscle tone. Trends Pharmacol. Sci. 1994, 15:407-408.
64. Salam M.T., Li Y.F., Langholz B., Gilliland F.D. Early-life environmental risk factors for asthma: Findings from the Children's Health Study. Environ. Health Perspect. 2004, 112:760-765.
65. Saunders B.C. Some Aspects of the Chemistry and Toxic Action of Organic Compounds Containing Phosphorus and Fluorine 1957, Cambridge, Univ. Press, London.
66. Sidell F.R. Human responses to intravenous VX. Technical Report No. 4082 1967, Edgewood Arsenal, Edgewood Arsenal, MD.
67. Sidell F.R. Soman and sarin: Clinical manifestations and treatment of accidental poisoning by organophosphates. Clin. Toxicol. 1974, 7:1-17.
68. Sidell F.R. Nerve agents. The Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Part I 1997, 129-179. Borden Institute, Washington, DC.
69. Stott W.T., McKenna M.J. The comparative absorption and excretion of chemical vapors by the upper, lower and intact respiratory tract of rats. Fundam. Appl. Toxicol. 1984, 4:594-602.
70. Suzuki H., Morita K., Kuriyama H. Innervation and properties of the smooth muscle of the dog trachea. Jpn. J. Physiol. 1976, 26:303-320.
71. Taylor P. Anticholinesterase agents. Goodman & Gilman's The Pharmacological Basis of Therapeutics 1996, 161-178. McGraw-Hill, New York. 9th ed. J.G. Hardman (Ed.).
72. Vojvodic V. Toxicology of War Gases 1981, Military Publishing House, Belgrade.
73. Waitt B.G.A.H. Gas Warfare: The Chemical Weapon, Its Use, and Protection Against It, Fighting Forces Series 1943, 1-9. Harper & Pearce, New York.
74. Ward J.R. Exposure to a nerve gas. Artificial Respiration: Theory and Applications 1962, 258-265. Harper & Row, New York. J.L. Whittenberger (Ed.).
75. West J.B. Respiratory Physiology-The Essentials 1995, Williams & Wilkins, Baltimore. 5th ed.
76. Wright P.G. An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit. J. Physiol. (London) 1954, 126:52-70.